March 20 (Reuters) - Durect Corp:
* DURECT ANNOUNCES FDA ADVISORY COMMITTEE MEETING FOR REMOXY® ER
* DURECT CORP - PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET DATE FOR REMOXY ER NDA IS AUGUST 7, 2018 Source text for Eikon: Further company coverage: